|
Feb 10, 2026 |
Wang Christopher Min Fang
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 4, 2026 |
Foust Warren
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 2, 2026 |
Feb 4, 2026 |
ANDREWS DEBORAH J
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 23, 2026 |
LeBuhn Richard T.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 12, 2026 |
Jan 14, 2026 |
Jiang Wei
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 9, 2026 |
Jan 13, 2026 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
62.5
|
+27,485
|
0.09%
|
✗
|
$606.1K |
| Jan 6, 2026 |
Jan 8, 2026 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
78.8
|
+406,653
|
0.53%
|
✗
|
$8.8M |
| Dec 11, 2025 |
Dec 12, 2025 |
SISITSKY NATHANIEL
|
Chief Legal Officer |
Sell |
22.5
|
-2,616
|
-10.29%
|
✗
|
$64.6K |
| Nov 19, 2025 |
Nov 21, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
95.0
|
+1,500,000
|
2.65%
|
✗
|
$41.1M |
| Nov 12, 2025 |
Nov 14, 2025 |
Jiang Wei
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 12, 2025 |
Aug 13, 2025 |
Jiang Wei
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 25, 2025 |
Jun 26, 2025 |
ANDREWS DEBORAH J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 25, 2025 |
Jun 26, 2025 |
Zhou Lilian Yansheng
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
SILVERMAN LOU
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Jiang Wei
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Zhou Lilian Yansheng
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Butcher Arthur C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 18, 2025 |
Jun 20, 2025 |
Lin Elizabeth Yeu
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 8, 2025 |
May 14, 2025 |
Michna Magda
|
Chief Development Officer |
Sell |
26.3
|
-1,675
|
-10.39%
|
✗
|
$32.7K |
| May 12, 2025 |
May 13, 2025 |
SILVERMAN LOU
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 12, 2025 |
May 13, 2025 |
Jiang Wei
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Apr 29, 2025 |
SILVERMAN LOU
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 8, 2025 |
Apr 10, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
70.0
|
+187,227
|
0.28%
|
✗
|
$2.9M |
| Apr 3, 2025 |
Apr 7, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
90.0
|
+845,220
|
1.08%
|
✗
|
$13.6M |
| Mar 31, 2025 |
Apr 2, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
62.5
|
+53,969
|
0.14%
|
✗
|
$941.3K |
| Mar 26, 2025 |
Mar 28, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
70.0
|
+113,384
|
0.23%
|
✗
|
$2M |
| Mar 21, 2025 |
Mar 25, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
70.0
|
+136,696
|
0.37%
|
✗
|
$2.4M |
| Mar 18, 2025 |
Mar 20, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
70.0
|
+201,844
|
0.42%
|
✗
|
$3.6M |
| Mar 14, 2025 |
Mar 18, 2025 |
Foust Warren
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
Michna Magda
|
Chief Development Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 14, 2025 |
Mar 18, 2025 |
SISITSKY NATHANIEL
|
Chief Legal Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 18, 2025 |
ANDREWS DEBORAH J
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2025 |
Mar 14, 2025 |
Foust Warren
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2025 |
Mar 14, 2025 |
Michna Magda
|
Chief Clinical, Regulatory |
Sell |
46.3
|
-2,435
|
-13.12%
|
✗
|
$43.8K |
| Mar 12, 2025 |
Mar 14, 2025 |
SISITSKY NATHANIEL
|
General Counsel |
Sell |
46.3
|
-2,334
|
-8.41%
|
✗
|
$42K |
| Mar 12, 2025 |
Mar 14, 2025 |
Williams Patrick F.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 7, 2025 |
Mar 11, 2025 |
Williams Patrick F.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2025 |
Mar 6, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
62.5
|
+27,953
|
0.08%
|
✗
|
$481.8K |
| Mar 5, 2025 |
Mar 6, 2025 |
FARRELL STEPHEN C
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2025 |
Mar 3, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
80.0
|
+663,761
|
0.81%
|
✗
|
$11.3M |
| Feb 26, 2025 |
Feb 28, 2025 |
FARRELL STEPHEN C
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 12, 2025 |
Feb 14, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
78.8
|
+411,430
|
0.62%
|
✗
|
$6.3M |
| Jan 14, 2025 |
Jan 16, 2025 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
62.5
|
+29,376
|
0.09%
|
✗
|
$630.8K |
| Jan 3, 2025 |
Jan 6, 2025 |
FRINZI THOMAS G
|
CEO |
Sell |
20.0
|
-10,775
|
-13.25%
|
✗
|
$264.4K |
| Dec 16, 2024 |
Dec 18, 2024 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
65.0
|
+80,200
|
0.15%
|
✗
|
$1.9M |
| Aug 12, 2024 |
Aug 19, 2024 |
Butcher Arthur C
|
Director |
Buy |
91.3
|
+1,315
|
45.45%
|
✗
|
$50K |
| Jun 20, 2024 |
Jun 24, 2024 |
FARRELL STEPHEN C
|
Director |
Neutral |
90.0
|
+2,244
|
17.38%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Zhou Lilian Yansheng
|
Director |
Neutral |
90.0
|
+2,244
|
96.43%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
WEISNER AIMEE S
|
Director |
Neutral |
90.0
|
+4,488
|
41.31%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Butcher Arthur C
|
Director |
Neutral |
90.0
|
+2,244
|
345.76%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Jiang Wei
|
Director |
Neutral |
90.0
|
+2,244
|
172.75%
|
✗
|
- |
| Jun 20, 2024 |
Jun 24, 2024 |
Lin Elizabeth Yeu
|
Director |
Neutral |
90.0
|
+2,244
|
78.60%
|
✗
|
- |
| May 9, 2024 |
May 13, 2024 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
47.5
|
+1
|
0.00%
|
✗
|
$42.6 |
| May 8, 2024 |
May 9, 2024 |
Foust Warren
|
COO |
Sell |
22.5
|
-2,418
|
-11.89%
|
✗
|
$99.2K |
| May 8, 2024 |
May 9, 2024 |
Michna Magda
|
Chief Clinical, Regulatory |
Sell |
22.5
|
-1,670
|
-11.89%
|
✗
|
$68.5K |
| Mar 14, 2024 |
Mar 14, 2024 |
WEISNER AIMEE S
|
Director |
Buy |
95.0
|
+1,750
|
19.20%
|
✗
|
$66.7K |
| Mar 12, 2024 |
Mar 14, 2024 |
FRINZI THOMAS G
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
Foust Warren
|
COO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
SISITSKY NATHANIEL
|
General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
Michna Magda
|
Chief Clinical, Regulatory |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
Williams Patrick F.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
Butcher Arthur C
|
Director |
Neutral |
90.0
|
+649
|
100.00%
|
✗
|
- |
| Mar 12, 2024 |
Mar 14, 2024 |
Jiang Wei
|
Director |
Neutral |
90.0
|
+1,299
|
100.00%
|
✗
|
- |
|
Mar 12, 2024 |
Butcher Arthur C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 12, 2024 |
Jiang Wei
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 7, 2024 |
Mar 11, 2024 |
Williams Patrick F.
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 8, 2024 |
Jan 10, 2024 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
52.5
|
+4,042
|
0.02%
|
✗
|
$109.6K |
| Jan 3, 2024 |
Jan 5, 2024 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
71.3
|
+226,553
|
0.43%
|
✗
|
$6.5M |
| Jan 3, 2024 |
Jan 3, 2024 |
FRINZI THOMAS G
|
CEO |
Sell |
20.0
|
-10,739
|
-11.67%
|
✗
|
$313.6K |
| Dec 29, 2023 |
Jan 2, 2024 |
WEISNER AIMEE S
|
Director |
Neutral |
90.0
|
+3,200
|
54.11%
|
✗
|
- |
| Dec 29, 2023 |
Jan 2, 2024 |
FARRELL STEPHEN C
|
Director |
Neutral |
85.0
|
+921
|
7.68%
|
✗
|
- |
| Dec 11, 2023 |
Dec 12, 2023 |
SISITSKY NATHANIEL
|
General Counsel |
Neutral |
90.0
|
+21,935
|
100.00%
|
✗
|
- |
|
Dec 12, 2023 |
SISITSKY NATHANIEL
|
General Counsel |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 6, 2023 |
Dec 6, 2023 |
Zhou Lilian Yansheng
|
Director |
Buy |
91.3
|
+850
|
57.55%
|
✗
|
$26.1K |
|
Dec 5, 2023 |
Kliman Gilbert H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 4, 2023 |
Dec 5, 2023 |
Zhou Lilian Yansheng
|
Director |
Neutral |
90.0
|
+1,477
|
100.00%
|
✗
|
- |
| Dec 1, 2023 |
Dec 4, 2023 |
Kliman Gilbert H
|
Director |
Neutral |
82.5
|
+366
|
3.63%
|
✗
|
- |
|
Dec 4, 2023 |
Zhou Lilian Yansheng
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Nov 28, 2023 |
Nov 30, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
80.0
|
+434,991
|
0.70%
|
✗
|
$13.7M |
| Nov 10, 2023 |
Nov 14, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
65.0
|
+34,827
|
0.12%
|
✗
|
$1.1M |
| Nov 7, 2023 |
Nov 9, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
78.8
|
+289,140
|
0.58%
|
✗
|
$9.7M |
| Nov 2, 2023 |
Nov 6, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
80.0
|
+309,154
|
0.64%
|
✗
|
$10.8M |
| Nov 6, 2023 |
Nov 6, 2023 |
FARRELL STEPHEN C
|
Director |
Neutral |
90.0
|
+3,000
|
33.37%
|
✗
|
- |
| Oct 4, 2023 |
Oct 6, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
78.8
|
+205,296
|
0.55%
|
✗
|
$7.8M |
| Sep 29, 2023 |
Oct 3, 2023 |
WEISNER AIMEE S
|
Director |
Neutral |
85.0
|
+497
|
9.17%
|
✗
|
- |
| Sep 29, 2023 |
Oct 3, 2023 |
Kliman Gilbert H
|
Director |
Neutral |
82.5
|
+435
|
4.50%
|
✗
|
- |
| Sep 29, 2023 |
Oct 3, 2023 |
FARRELL STEPHEN C
|
Director |
Neutral |
85.0
|
+715
|
8.64%
|
✗
|
- |
| Sep 21, 2023 |
Sep 22, 2023 |
Lin Elizabeth Yeu
|
Director |
Buy |
95.0
|
+2,500
|
704.23%
|
✗
|
$100K |
| Sep 19, 2023 |
Sep 21, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
80.0
|
+291,383
|
0.80%
|
✗
|
$11.7M |
| Sep 5, 2023 |
Sep 7, 2023 |
BROADWOOD PARTNERS, L.P.
|
10% Owner |
Buy |
78.8
|
+189,962
|
0.54%
|
✗
|
$7.9M |
| Aug 10, 2023 |
Aug 11, 2023 |
Williams Patrick F.
|
CFO |
Sell |
22.5
|
-2,539
|
-5.59%
|
✗
|
$112K |
| Aug 7, 2023 |
Aug 7, 2023 |
WEISNER AIMEE S
|
Director |
Buy |
95.0
|
+2,000
|
58.53%
|
✗
|
$97.4K |
| Jun 15, 2023 |
Jun 16, 2023 |
FRINZI THOMAS G
|
CEO |
Sell |
36.3
|
-501
|
-0.54%
|
✗
|
$26.4K |
| Jun 15, 2023 |
Jun 16, 2023 |
FARRELL STEPHEN C
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Kliman Gilbert H
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
WEISNER AIMEE S
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Yu K Peony
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 15, 2023 |
Jun 16, 2023 |
Lin Elizabeth Yeu
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 6, 2023 |
Jun 7, 2023 |
Williams Patrick F.
|
CFO |
Sell |
22.5
|
-1,987
|
-4.19%
|
✗
|
$108.9K |
| May 8, 2023 |
May 9, 2023 |
Michna Magda
|
Chief Clinical, Regulatory |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |